The Cancer Therapeutics Program consists of a collaborative network of basic science and clinical investigators spanning a range of experimental and developmental therapeutics.

The Program's themes include: (1) identification of new therapeutic targets and drug discovery, (2) drug development and (3) clinical investigations and correlative studies performed on patient tissues.  This fundamental linkage of drug discovery, drug development, and clinical investigation both defines the overall goals of the Program and provides the basis for extensive intra- and inter-programmatic collaborations.  

Programmatic goals are: (1) to enhance and facilitate programmatic interactions and collaborations between basic scientists and clinical investigators in cancer therapeutics, (2) to promote the discovery, development, and application of novel therapeutic approaches and (3) to develop translational and laboratory-based clinical investigations of new therapeutic agents or approaches.

View cancer therapeutics members